Dobutamine potentiates arterial chemoreflex sensitivity in healthy normal humans

Sonia Velez-Roa, Baktybek Kojonazarov, Agnieszka Ciarka, Pascal Godart, Robert Naeije, Virend Somers, Philippe Van de Borne

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

β-Adrenergic agonists may increase chemosensitivity in humans. We tested the hypothesis that the β1-agonist dobutamine increases peripheral chemosensitivity in a double-blind placebo-controlled randomized and crossover study. In 15 healthy subjects, we examined the effects of dobutamine on breathing, hemodynamics, and sympathetic nerve activity (measured using microneurography) during normoxia, isocapnic hypoxia (10% O2), posthypoxic maximal voluntary end-expiratory apnea, hyperoxic hypercapnia, and cold pressor test (CPT). Dobutamine increased ventilation (7.5 ± 0.3 vs. 6.7 ± 0.2 l/min, P = 0.0004) during normoxia, markedly enhanced the ventilatory (16.1 ± 1.6 vs. 11.4 ± 0.7 l/min, P < 0.0001) and sympathetic (+403 ± 94 vs. +222 ± 5%, P < 0.03) responses at the fifth minute of isocapnic hypoxia, and enhanced the sympathetic response to the apnea performed after hypoxia (+501 ± 107% vs. +291 ± 38%, P < 0.05). No differences were observed between dobutamine and placebo on the responses to hyperoxic hypercapnia and CPT. Dobutamine increases ventilation during normoxia and potentiates the ventilatory and sympathetic responses to hypoxia in healthy subjects. Dobutamine does not affect the responses to hyperoxic hypercapnia and CPT. We conclude that dobutamine enhances peripheral chemosensitivity.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume285
Issue number3 54-3
StatePublished - Sep 1 2003

Fingerprint

Dobutamine
Hypercapnia
Apnea
Ventilation
Healthy Volunteers
Placebos
Adrenergic Agonists
Cross-Over Studies
Respiration
Hemodynamics
Hypoxia

Keywords

  • Hypoxia

ASJC Scopus subject areas

  • Physiology

Cite this

Velez-Roa, S., Kojonazarov, B., Ciarka, A., Godart, P., Naeije, R., Somers, V., & Van de Borne, P. (2003). Dobutamine potentiates arterial chemoreflex sensitivity in healthy normal humans. American Journal of Physiology - Heart and Circulatory Physiology, 285(3 54-3).

Dobutamine potentiates arterial chemoreflex sensitivity in healthy normal humans. / Velez-Roa, Sonia; Kojonazarov, Baktybek; Ciarka, Agnieszka; Godart, Pascal; Naeije, Robert; Somers, Virend; Van de Borne, Philippe.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 285, No. 3 54-3, 01.09.2003.

Research output: Contribution to journalArticle

Velez-Roa, S, Kojonazarov, B, Ciarka, A, Godart, P, Naeije, R, Somers, V & Van de Borne, P 2003, 'Dobutamine potentiates arterial chemoreflex sensitivity in healthy normal humans', American Journal of Physiology - Heart and Circulatory Physiology, vol. 285, no. 3 54-3.
Velez-Roa, Sonia ; Kojonazarov, Baktybek ; Ciarka, Agnieszka ; Godart, Pascal ; Naeije, Robert ; Somers, Virend ; Van de Borne, Philippe. / Dobutamine potentiates arterial chemoreflex sensitivity in healthy normal humans. In: American Journal of Physiology - Heart and Circulatory Physiology. 2003 ; Vol. 285, No. 3 54-3.
@article{267793cabf6244dea54ecd6fca55642a,
title = "Dobutamine potentiates arterial chemoreflex sensitivity in healthy normal humans",
abstract = "β-Adrenergic agonists may increase chemosensitivity in humans. We tested the hypothesis that the β1-agonist dobutamine increases peripheral chemosensitivity in a double-blind placebo-controlled randomized and crossover study. In 15 healthy subjects, we examined the effects of dobutamine on breathing, hemodynamics, and sympathetic nerve activity (measured using microneurography) during normoxia, isocapnic hypoxia (10{\%} O2), posthypoxic maximal voluntary end-expiratory apnea, hyperoxic hypercapnia, and cold pressor test (CPT). Dobutamine increased ventilation (7.5 ± 0.3 vs. 6.7 ± 0.2 l/min, P = 0.0004) during normoxia, markedly enhanced the ventilatory (16.1 ± 1.6 vs. 11.4 ± 0.7 l/min, P < 0.0001) and sympathetic (+403 ± 94 vs. +222 ± 5{\%}, P < 0.03) responses at the fifth minute of isocapnic hypoxia, and enhanced the sympathetic response to the apnea performed after hypoxia (+501 ± 107{\%} vs. +291 ± 38{\%}, P < 0.05). No differences were observed between dobutamine and placebo on the responses to hyperoxic hypercapnia and CPT. Dobutamine increases ventilation during normoxia and potentiates the ventilatory and sympathetic responses to hypoxia in healthy subjects. Dobutamine does not affect the responses to hyperoxic hypercapnia and CPT. We conclude that dobutamine enhances peripheral chemosensitivity.",
keywords = "Hypoxia",
author = "Sonia Velez-Roa and Baktybek Kojonazarov and Agnieszka Ciarka and Pascal Godart and Robert Naeije and Virend Somers and {Van de Borne}, Philippe",
year = "2003",
month = "9",
day = "1",
language = "English (US)",
volume = "285",
journal = "American Journal of Physiology - Renal Fluid and Electrolyte Physiology",
issn = "1931-857X",
publisher = "American Physiological Society",
number = "3 54-3",

}

TY - JOUR

T1 - Dobutamine potentiates arterial chemoreflex sensitivity in healthy normal humans

AU - Velez-Roa, Sonia

AU - Kojonazarov, Baktybek

AU - Ciarka, Agnieszka

AU - Godart, Pascal

AU - Naeije, Robert

AU - Somers, Virend

AU - Van de Borne, Philippe

PY - 2003/9/1

Y1 - 2003/9/1

N2 - β-Adrenergic agonists may increase chemosensitivity in humans. We tested the hypothesis that the β1-agonist dobutamine increases peripheral chemosensitivity in a double-blind placebo-controlled randomized and crossover study. In 15 healthy subjects, we examined the effects of dobutamine on breathing, hemodynamics, and sympathetic nerve activity (measured using microneurography) during normoxia, isocapnic hypoxia (10% O2), posthypoxic maximal voluntary end-expiratory apnea, hyperoxic hypercapnia, and cold pressor test (CPT). Dobutamine increased ventilation (7.5 ± 0.3 vs. 6.7 ± 0.2 l/min, P = 0.0004) during normoxia, markedly enhanced the ventilatory (16.1 ± 1.6 vs. 11.4 ± 0.7 l/min, P < 0.0001) and sympathetic (+403 ± 94 vs. +222 ± 5%, P < 0.03) responses at the fifth minute of isocapnic hypoxia, and enhanced the sympathetic response to the apnea performed after hypoxia (+501 ± 107% vs. +291 ± 38%, P < 0.05). No differences were observed between dobutamine and placebo on the responses to hyperoxic hypercapnia and CPT. Dobutamine increases ventilation during normoxia and potentiates the ventilatory and sympathetic responses to hypoxia in healthy subjects. Dobutamine does not affect the responses to hyperoxic hypercapnia and CPT. We conclude that dobutamine enhances peripheral chemosensitivity.

AB - β-Adrenergic agonists may increase chemosensitivity in humans. We tested the hypothesis that the β1-agonist dobutamine increases peripheral chemosensitivity in a double-blind placebo-controlled randomized and crossover study. In 15 healthy subjects, we examined the effects of dobutamine on breathing, hemodynamics, and sympathetic nerve activity (measured using microneurography) during normoxia, isocapnic hypoxia (10% O2), posthypoxic maximal voluntary end-expiratory apnea, hyperoxic hypercapnia, and cold pressor test (CPT). Dobutamine increased ventilation (7.5 ± 0.3 vs. 6.7 ± 0.2 l/min, P = 0.0004) during normoxia, markedly enhanced the ventilatory (16.1 ± 1.6 vs. 11.4 ± 0.7 l/min, P < 0.0001) and sympathetic (+403 ± 94 vs. +222 ± 5%, P < 0.03) responses at the fifth minute of isocapnic hypoxia, and enhanced the sympathetic response to the apnea performed after hypoxia (+501 ± 107% vs. +291 ± 38%, P < 0.05). No differences were observed between dobutamine and placebo on the responses to hyperoxic hypercapnia and CPT. Dobutamine increases ventilation during normoxia and potentiates the ventilatory and sympathetic responses to hypoxia in healthy subjects. Dobutamine does not affect the responses to hyperoxic hypercapnia and CPT. We conclude that dobutamine enhances peripheral chemosensitivity.

KW - Hypoxia

UR - http://www.scopus.com/inward/record.url?scp=0041857963&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041857963&partnerID=8YFLogxK

M3 - Article

C2 - 12750069

AN - SCOPUS:0041857963

VL - 285

JO - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

JF - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

SN - 1931-857X

IS - 3 54-3

ER -